Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Codex Dna Inc (NQ: DNAY )

N/A UNCHANGED
Last Price Updated: 3:59 PM EST, Jan 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Codex Dna Inc

< Previous 1 2 3 Next >
Mid-Afternoon Market Update: Dow Drops 1%; Snap One Shares Plunge
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 350 points on Wednesday. The Dow traded down 1.05% to 34,442.47 while the NASDAQ fell 1.09... 
Via Benzinga
Mid-Day Market Update: Nasdaq Turns Positive; 4D pharma Shares Jump
The Nasdaq Composite turned higher midway through trading on Wednesday. The Dow traded down 0.69% to 34,566.59 while the NASDAQ rose 0.28% to 14,148.16. The S&P also fell... 
Via Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
Gainers Allego N.V. (NYSE: ALLG) shares jumped 158.5% to $21.41 after the company announced the completion of its merger agreement with Spartan Acquisition Corp., which resulted... 
Via Benzinga
Looking Into Codex DNA's Return On Capital Employed
Benzinga Pro data, Codex DNA (NASDAQ:DNAY) reported Q4 sales of $3.08 million. Earnings fell to a loss of $12.49 million, resulting in a 27.15% decrease from last quarter. In Q3... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; General Mills Posts Upbeat Earnings
U.S. stocks opened on downbeat note this morning, with the Dow Jones dropping more than 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.80%... 
Via Benzinga
Earnings Scheduled For March 22, 2022
Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (... 
Via Benzinga
45 Stocks Moving In Friday's Mid-Day Session
Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 62.4% to $1.5500. DiDi Global Inc. (NYSE: DIDI) shares climbed 46% to $3.73. Kidpik Corp. (NASDAQ: PIK) shares... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
47 Biggest Movers From Yesterday
Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Agile Therapeutics (NASDAQ:AGRX) ... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Nuvectis Pharma (NASDAQ:NVCT) stock moved upwards by 132.3% to $7.55 during Monday's regular session. The current volume of 17.0 million shares is 2307.5% of... 
Via Benzinga
32 Stocks Moving In Monday's Mid-Day Session
Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) jumped 191.2% to $9.47. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH) shares jumped 51% to $18.... 
Via Benzinga
Pfizer Continues Its Covid Makeover: What's Next For This Hot Stock?
How the pandemic continued a transformation Pfizer says began years ago. 
Via Investor's Business Daily
52 Biggest Movers From Friday
Gainers Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its... 
Via Benzinga
Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer
Pfizer and Bayer inked deals with several companies in gene-editing. 
Via Investor's Business Daily
Why Codex DNA Shares Are Trading Higher Today?
Pfizer Inc (NYSE: PFE) has signed on two partners in an effort to become an mRNA powerhouse. Pfizer will offer milestone payments of over $100 million to ... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Nutriband (NASDAQ:NTRB) stock moved upwards by 186.7% to $11.21 during Friday's regular session. The current volume of 101.5 million shares is 7226.8% of... 
Via Benzinga
63 Biggest Movers From Yesterday
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its... 
Via Benzinga
45 Biggest Movers From Yesterday
Gainers Puxin Limited (NYSE: NEW) shares surged 80% to close at $0.54 on Wednesday after reporting results for the second quarter. United Time Technology Co., Ltd. (NASDAQ: UTME... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Cognition Therapeutics (NASDAQ:CGTX 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Biofrontera (NASDAQ: 
Via Benzinga
26 Stocks Moving In Wednesday's Mid-Day Session
Gainers Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter. ShiftPixy, Inc. (NASDAQ: PIXY) climbed 38.4% to $1.55 after surging 43... 
Via Benzinga
54 Biggest Movers From Thursday
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Pasithea Therapeutics (NASDAQ: 
Via Benzinga
Codex DNA, Inc. (DNAY) Q3 2021 Earnings Call Transcript
DNAY earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:... 
Via Benzinga
Exposures COVID-19
Codex DNA Clocks Q3 Sales Growth Of 75%; Acquires Eton Bioscience For $13M
Codex DNA Inc's (NASDAQ: DNAY) Q3 revenues increased 75% Y/Y to $2.8 million. The total fell short of the consensus Wall Street estimate of $2.93 million. Q3 was... 
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized... 
Via Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics... 
Via Benzinga
Exposures COVID-19
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.